XILOIAL

XILOIAL FORTE SINGLE-DOSE 20 MINI CONTAINERS OF 0.5ML

XILOIAL FORTE SINGLE-DOSE 20 MINI CONTAINERS OF 0.5ML

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet

Xiloial FORTE

CE medical device. Ophthalmic solution based on Ts-Polysaccharide containing high molecular weight hyaluronic acid, obtained through biotechnological synthesis. Hyaluronic acid is a substance that produces mucomimetic solutions with high lubricating properties; the viscosity of these solutions is such as to allow for a high hydrating effect and stabilization of the tear film. Ts-Polysaccharide is a plant-based substance, extracted from the seeds of the tamarind plant (Tamarindus Indica), useful for protecting the corneal-conjunctival surface. Ts-Polysaccharide forms a protective film on the ocular surface that helps restore the normal physiological balance of the tear film and the ocular surface. The combination of the two substances therefore allows for a synergistic protection of the corneal/conjunctival surface from irritation caused by physical environmental factors (wind, prolonged exposure to sunlight, cigarette smoke, dry air), visual stress (intense eye strain, computer screens), or mechanical factors (contact lenses, eye surgery). The concentration of the mixture is calibrated to allow lubrication even in cases of the most intense discomfort.

How to use
After opening the protective pouch, separate one vial from the others. Open the vial by twisting and pulling the cap. Inject one drop of Xiloial mono into the eye, applying gentle pressure to the body of the vial. This procedure can be repeated several times a day, as needed.

Warnings
The product is for external ophthalmic use only. After administration, temporary blurred vision may occur, which disappears within a few minutes. It is advisable to wait for the blurred vision to disappear before undertaking any activity requiring clear vision (driving, operating machinery, etc.). Do not use Xiloial Forte if the vial is damaged. Avoid touching the eye with the tip of the vial. Do not use if you have a known incompatibility with any component of the preparation. Allow 10-15 minutes between instilling Xiloial Forte and any other medications for external ophthalmic use. Do not use the product after the expiration date indicated on the package. The formulation contains no preservatives. Xiloial Forte is packaged in convenient resealable vials that allow for repeated use throughout the day. Keep the preparation out of reach of children. Do not swallow.

Conservation
Store below 25°C. Use each vial within 12 hours of opening. Do not dispose of the vial in the environment after use.

Components
Hyaluronic acid; Ts-polysaccharide; mannitol; sodium phosphate monobasic monohydrate; sodium phosphate dibasic dodecahydrate; water for injections.

Format
20 resealable 0.5 ml vials without preservatives.

XILOIAL

XILOIAL FORTE SINGLE-DOSE 20 MINI CONTAINERS OF 0.5ML

XILOIAL FORTE SINGLE-DOSE 20 MINI CONTAINERS OF 0.5ML

MINSAN code: 930773748
Previous price: €22,85
Regular price €22,85
Regular price €0,00 Sale price €22,85
-% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.